These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 12063908)
1. Premenstrual dysphoric disorder. A guide for the treating clinician. Elliott H N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908 [TBL] [Abstract][Full Text] [Related]
2. [The premenstrual syndrome]. van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012 [TBL] [Abstract][Full Text] [Related]
3. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate. Dunphy L; Boyle S; Wood F BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030 [TBL] [Abstract][Full Text] [Related]
4. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents. Itriyeva K Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402 [TBL] [Abstract][Full Text] [Related]
5. Premenstrual syndrome: A mini review. Ryu A; Kim TH Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143 [TBL] [Abstract][Full Text] [Related]
6. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review]. Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319 [TBL] [Abstract][Full Text] [Related]
7. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents. Rapkin AJ; Mikacich JA Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867 [TBL] [Abstract][Full Text] [Related]
8. [Premenstrual syndrome and premenstrual dysphoric disorder]. Kovács Z; Hegyi G; Szőke H Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486 [TBL] [Abstract][Full Text] [Related]
9. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder. Frackiewicz EJ; Shiovitz TM J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908 [TBL] [Abstract][Full Text] [Related]
10. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Steiner M; Pearlstein T; Cohen LS; Endicott J; Kornstein SG; Roberts C; Roberts DL; Yonkers K J Womens Health (Larchmt); 2006; 15(1):57-69. PubMed ID: 16417420 [TBL] [Abstract][Full Text] [Related]
12. [Premenstrual Dysphoric Disorder (PMDD) as an independent disease]. Passow D; Bolz M Fortschr Neurol Psychiatr; 2012 Jul; 80(7):382-7. PubMed ID: 22760509 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors for premenstrual syndrome. Brown J; O' Brien PM; Marjoribanks J; Wyatt K Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564 [TBL] [Abstract][Full Text] [Related]
14. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Jarvis CI; Lynch AM; Morin AK Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957 [TBL] [Abstract][Full Text] [Related]
15. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. Steiner M J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297 [TBL] [Abstract][Full Text] [Related]
16. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder. Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267 [TBL] [Abstract][Full Text] [Related]
17. PMS and PMDD in the domain of mental health nursing. Stearns S J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):16-27. PubMed ID: 11197992 [TBL] [Abstract][Full Text] [Related]